ELLA LOWERY LYNCH: Open Payments
NPI 1184611139 · PEMBROKE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 50 payments from 10 companies in 2025. Trend: 2023 $875 · 2024 $578 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $215 |
| ABBVIE INC. | 13 | $201 |
| Alkermes, Inc. | 4 | $96 |
| Janssen Pharmaceuticals, Inc | 5 | $88 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Tris Pharma Inc | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Qelbree, VRAYLAR, ARISTADA, Jornay PM, REXULTI, Dyanavel XR, INVEGA SUSTENNA, SPRAVATO.
Industry payments across NC — which companies pay providers there.
